NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/09/2026
Back to search
Official data from USPTO
CELLTHERX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLTHERX
ST13
US500000098440066Class
5, 10
Filing
98440066
Registration
8296676
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/09/2026
Trademark type
Word
Nice classes
5, 10
Filing date
03/08/2024
Registration date
06/09/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2025-07-00
First use in commerce
2025-07-00
Drawing code
4
Owner type
03
Owner location
Dallas, TX, US
Examiner
CHOSID, ROBIN S
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CellTherX Corp
Representatives
Matthew T. Kramer Snell & Wilmer LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Tissue-based productsbiological tissue grafts for use in dentalmedicalsurgical procedures and applications; Pharmaceutical preparations and substancesbiological tissue grafts for use in regenerative medicinewound repairsurgical repair; Wound healing systembiological tissue grafting materials for use in regenerative medicinewound repairsurgical repair; Biological tissue grafts; Surgical implants made of biological materials for use in soft tissue
Class 10
Surgical apparatus and instruments for medical and dental use; Surgical implants made of synthetic materials for use in soft tissue; Medical devicesnamely templates for use in creating tissue grafts; Synthetic tissue grafting materials for use in dentalmedicalsurgical procedures and applications; Pharmaceutical preparations and substancessynthetic tissue grafting materials for use in regenerative medicinewound repairsurgical repair; Electronic medical appliances for wound healing
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/15/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/15/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/28/2026
IUAF
USE AMENDMENT FILED
12/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
EX1G
SOU EXTENSION 1 GRANTED
06/03/2025
EXT1
SOU EXTENSION 1 FILED
06/02/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/14/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/05/2024
PUBO
PUBLISHED FOR OPPOSITION
11/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/16/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/25/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/21/2024
GNRT
NON-FINAL ACTION E-MAILED
09/21/2024
CNRT
NON-FINAL ACTION WRITTEN
09/21/2024
DOCK
ASSIGNED TO EXAMINER
09/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2024
NWAP
NEW APPLICATION ENTERED
03/08/2024
Continuous trademark protection
Get notified about every new filing that threatens CELLTHERX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.